Radiobiologists examine the effects of radiation on living organisms, particularly how it impacts cells, tissues, and DNA. Their work is essential in both medical and environmental contexts. Radiation can damage cells, leading to mutations, cell death, or long-term health effects, including cancer. By examining these processes, radiobiologists help improve radiation therapy for cancer treatment, ensuring that radiation effectively targets tumors while minimizing harm to surrounding healthy tissues.
In cancer treatment, radiobiologists work alongside oncologists to optimize radiation therapy. They assist in determining the right doses, delivery methods, and treatment schedules to maximize tumor destruction while reducing side effects. Radiobiologists also examine how different tumors respond to radiation and explore methods to make cancer cells more sensitive to treatment. Additionally, they research radioprotective agents that help shield healthy tissues during radiation therapy. Their work is vital in advancing precision medicine, offering more tailored approaches for each patient. Radiobiologists also study how various external factors, such as age and genetics, affect the body’s response to radiation. Outside of cancer care, radiobiologists examine the risks of radiation exposure in various environments, such as workplaces and the natural environment. Their research ensures the safe and effective use of radiation across various fields, ultimately improving cancer treatments and public health safety.
Title : A novel blood-based mRNA genomics technology for cancer diagnosis and treatment
Rajvir Dahiya, University of California San Francisco, United States
Title : tRNA-derived fragment 3′tRF-AlaAGC modulates cell chemoresistance and M2 macrophage polarization via binding to TRADD in breast cancer
Feng Yan, The Affiliated Cancer Hospital of Nanjing Medical University, China
Title : Integrating single-cell and spatial transcriptomics to uncover and elucidate GP73-mediated pro-angiogenic regulatory networks in hepatocellular carcinoma
Jiazhou Ye, Guangxi Medical University Cancer Hospital, China
Title : Unveiling the synergism of radiofrequency therapy and graphene nanocomposite in tumor cell viability assay
Paulo Cesar De Morais, Catholic University of Brasilia, Brazil
Title : Analysis of the dynamic evolution and influencing factors of nutritional risk in breast cancer patients during treatment
Jingwen Yan, Sun Yat-sen University, China
Title : Integrative multi-omics reveals metabolic–stemness coupling and novel therapeutic targets in osteosarcoma chemoresistance
Jinyan Feng, Tianjin Medical University Cancer Institute and Hospital, China